Interface temp rises during lattice-tip PFA vary by site, with RSPV often blunted. Temp rise correlates with lesion depth—real-time feedback? @johnpowermd @jskoruth #Epeeps @VivekReddyMD @DrKeitaW ahajrnls.org/49IGFwU

The year in cardiovascular medicine 2025: the top 10 papers in cardio-oncology academic.oup.com/eurheartj/a… @DrJESalem @CardioOncology @JohnPowerMD

Dr. Hu is building something big!

At last—our analysis predicting severe outcomes in ICI-myocarditis is out. With just ECG, LVEF, troponin, and clinical history, you can estimate risk at initial presentation. Grateful for the incredible mentorship @CardioOncology @DrJESalem .. true world-class investigators!

🚨Out now in @ESC_Journals 🚨- Our review on the growing use of AI/digital tools in cardiology trials! Lots of opportunities (also pitfalls) for CV researchers. Thx to @CVCTForum & my awesome co-authors @lamcardio @FaiezZANNAD @ruey_hu. 📖 Read it here: doi.org/10.1093/eurheartj/eh…

Congratulations to Dr. Srinivas Dukkipati & Dr. Vivek Reddy at Mt. Sinai Hospital in NYC for their first cases with the Affera™ Mapping and Ablation System & all-in-one, dual energy, Sphere-9™ catheter. Learn more: bit.ly/4fpuk1C See risk info: bit.ly/3CsuSVN

Learned a lot at @HRS2024 sharing @UCSDCardiology experience identifying and treating crux VTs with ablation at the CS os @GordonHo_EP

Massive achievement by @kevingbuell who used ML to personalize ICU care where RCTs haven't found benefit - O2 goals! Exciting work from this star @VUMCMedicineRes coresident

Look at this treasure trove of data on arrhythmic mitral valve prolapse coming from sub studies of the #PRIMARY trial - TEER vs primary repair for degenerative MR @CVCTForum @MountSinaiHeart @CTSN16

Only 1 in 8 patients with cardiovascular disease are diagnosed before the onset of symptoms, Dr @rohan_khera notes @CVCTForum. Work from @cards_lab @YaleCardiology by @LovedeepDhingra @ekoikonomou @PhyllisTweets @Veer_Sangha_ @AryaAminorroaya @aakhunte has shown that #AIECG can augment human capacity to identify pre-symptomatic disease, including LV systolic dysfunction, HCM, amyloid, and severe valve disease. Scalable deployment of AI-ECG can enhance patient discovery, detect disease, and monitor response to trials.

Elated to be joining @MountSinaiHeart for EP fellowship next year!! Can’t wait! #EPeeps #Match2024

Poster presentation by fellow @JohnPowerMD with mentor Dr. Green on transvenous lead extraction at time of device upgrade. @UCSDCardFellows #AHA23

Congratulations to third year fellow @JohnPowerMD on his new publication @NatureMedicine. ICI-myocarditis incidence and severity is associated with thymic cancer and thymic dysfunction @UCSDCardFellows @ucsdim @UCSDHealth nature.com/articles/s41591-0…